Administration Semaglutide Administration: Administered as a once-weekly injection, making it convenient for patients who prefer not to take daily medications
The most effective treatment is not always the one with the biggest weight loss number in a study
1 The 14 mg dose of Rybelsus produced around 4 kg, roughly 4 to 5% of body weight, in people living with type 2 diabetes
DeFronzo RA, Okerson T, Viswanathan P, Guan X, Holcombe JH, MacConell L
Food and Drug Administration (FDA) approved the injectable version of semaglutide with the brand name Ozempic for use by people with diabetes
Discreet packaging, secure messaging, and your data never sold